Viewing Study NCT03407859


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2025-12-27 @ 9:34 PM
Study NCT ID: NCT03407859
Status: RECRUITING
Last Update Posted: 2024-03-15
First Post: 2017-04-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sequential Treatment With CD20/CD22/CD10-CART After CD19-CART Treatment Base on MRD in Relapsed/Refractory B-ALL
Sponsor: Zhujiang Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module